ASCIA News
-
Novalac Allergy infant formula supply update
14 June 2019: Bayer Australia Ltd (Bayer) is advising healthcare professionals and consumers that limited stock of Novalac Allergy will be available and released to pharmacies in Australia during June, July and August. Intermittent supply and limited availability in pharmaci... -
Order of Australia award for Professor Constance (Connie) Katelaris AM
11 June 2019: It is with great pleasure that we confirm that an Order of Australia has been awarded to Professor Constance Katelaris AM. Professor Constance Katelaris has made substantial contributions to the fields of allergy and clinical immunology, the Australasian Societ... -
Probiotic and egg OIT study in Victoria
31 May 2019: The Murdoch Children’s Research Institute (MCRI) in Victoria is conducting a trial to evaluate probiotic and egg oral immunotherapy (OIT), which is a possible new treatment for egg allergy. This trial is currently recruiting children and teenagers aged between 5... -
Food Allergy Week - 26 May to 1 June 2019
29 May 2019: The main aim of Food Allergy Week 2019 is to raise awareness of food allergy. To coincide with this event, two important new resources are available: The national patient organisation Allergy & Anaphylaxis Australia (A&AA) has released a webinar video Food Aller... -
ASCIA 2019 Conference registration and abstract submission is now open
28 May 2019: With an outstanding program featuring 9 international speakers and a venue located on the spectacular Swan River in Perth, this conference is sure to be a highlight of the year for ASCIA members and other health professionals with an interest in allergy and clin... -
Updated ASCIA article on oral immunotherapy (OIT) for food allergy
24 May 2019: ASCIA has updated its information on oral immunotherapy (OIT) for food allergy to include information from a meta-analysis (a method to combine data from multiple studies) of 12 OIT trials. This meta-analysis was published in the Lancet journal in April 2019 and... -
ASCIA patient education resources reborn
22 May 2019: The team at ASCIA is pleased to announce that stage three of the ASCIA Education Project is now complete. More than sixty ASCIA website articles for patients, consumers and carers underwent a comprehensive review over the past few months. The review focused on m... -
Recent tick allergy publication supports ASCIA recommendations
7 May 2019: The ASCIA article on tick allergy has been updated to include reference to a recently published study, and is available at www.allergy.org.au/patients/insect-allergy-bites-and-stings/tick-allergy The study is titled “Tick killing in situ before removal to prevent...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information.Verify here.